New Current Report Filed with the SEC Disclosing Occurrence of a Material Impairment: 8-K – Opexa Therapeutics, Inc. (0001069308) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing the occurrence of a material impairment. Details of the current report are:

8-K – Opexa Therapeutics, Inc. (0001069308) (Filer)
Filed: 2017-02-01 AccNo: 0001654954-17-000639 Size: 87 KB

Item 1.02: Termination of a Material Definitive Agreement

Item 2.01: Completion of Acquisition or Disposition of Assets

Item 2.05: Cost Associated with Exit or Disposal Activities

Item 2.06: Material Impairments

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item 8.01: Other Events

Item 9.01: Financial Statements and Exhibits
Filing Date: 2017-02-01T07:30:42-05:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/1069308/000165495417000639/0001654954-17-000639-index.htm